Literature DB >> 18671285

Regulation of complement-3 protein expression in human and mouse oviducts.

Yin-Lau Lee1, Ana W Y Cheong, Wang-Ngai Chow, Kai-Fai Lee, William S B Yeung.   

Abstract

The human oviduct derived embryotrophic factor-3 (ETF-3) contains complement protein-3 (C3) and its derivates. Although C3 is not embryotrophic, it is converted into the embryotrophic derivative, iC3b in the presence of embryos and oviductal cells. The regulation of C3 production in the oviduct is not known. The objectives of this study were to investigate the effects of presence of preimplantation embryos and hormones on C3 expression in the oviducts in vitro and in vivo. The expression of C3 in the oviduct of pregnant mice was compared to that of pseudo-pregnant mice. The hormonal action on C3 expression was studied in the ovariectomized mouse oviducts and human oviductal epithelial (OE) cells. The results showed that the level of C3 mRNA in the mouse oviduct was high on Day 1 and Day 2, but decreased to a minimum on Day 4 of pregnancy, whereas that of pseudo-pregnancy remained relatively stable within the same period. The protein levels of C3 and iC3b specific fragments, alpha-115 and alpha-40, respectively in the mouse oviductal luminal fluid were highest on Day 3 of pregnancy, when the embryos were expected to be most sensitive to the embryotrophic activity of ETF-3. Estrogen elevated C3 expression in the ovariectomized mouse oviduct and the OE cells. Progesterone suppressed estrogen-induced C3 expression in the mouse oviduct, but had no effect on OE cells. In conclusion, the presence of embryo and steroid hormones regulate the synthesis and secretion of oviductal C3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18671285     DOI: 10.1002/mrd.20955

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

1.  Proteomes of the Female Genital Tract During the Oestrous Cycle.

Authors:  Clement Soleilhavoup; Cindy Riou; Guillaume Tsikis; Valerie Labas; Gregoire Harichaux; Philippa Kohnke; Karine Reynaud; Simon P de Graaf; Nadine Gerard; Xavier Druart
Journal:  Mol Cell Proteomics       Date:  2015-10-30       Impact factor: 5.911

Review 2.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 3.  The Microbiome and Complement Activation: A Mechanistic Model for Preterm Birth.

Authors:  Alexis B Dunn; Anne L Dunlop; Carol J Hogue; Andrew Miller; Elizabeth J Corwin
Journal:  Biol Res Nurs       Date:  2017-01-11       Impact factor: 2.522

Review 4.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

5.  Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice.

Authors:  Juan M Gonzalez; Claus-Werner Franzke; Fengyuan Yang; Roberto Romero; Guillermina Girardi
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

6.  Annexin A2 Acts as an Adhesion Molecule on the Endometrial Epithelium during Implantation in Mice.

Authors:  Bing Wang; Tian-Min Ye; Kai-Fai Lee; Philip C N Chiu; Ronald T K Pang; Ernest H Y Ng; William S B Yeung
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 7.  Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.

Authors:  Guillermina Girardi; Joshua J Lingo; Sherry D Fleming; Jean F Regal
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.